Number readmitted (%) |
9 (12.5) |
10 (25.0) |
0 (0.0) |
0 (0.0) |
1 (3.8) |
Median age (IQR) - years |
61 (49–78) |
51 (41–65) |
56 (40–66) |
64 (48–70) |
55 (49–67) |
Sex |
Males (%) |
37 (51.4) |
23 (57.5) |
12 (46.2) |
15 (46.9) |
15 (57.7) |
Females (%) |
35 (48.6) |
17 (42.5) |
14 (53.8) |
17 (53.1) |
11 (42.3) |
Ethnicity (%) |
White |
27 (37.5) |
19 (47.5) |
10 (38.5) |
10 (31.3) |
9 (34.6) |
Black |
11 (15.3) |
8 (20.0) |
1 (3.8) |
5 (15.6) |
5 (19.2) |
South Asian |
7 (9.7) |
1 (2.5) |
3 (11.5) |
3 (9.4) |
3 (11.5) |
Other Asian |
7 (9.7) |
0 (0.0) |
3 (11.5) |
1 (3.1) |
2 (7.7) |
Unknown |
20 (27.8) |
12 (30.0) |
9 (34.6) |
13 (40.6) |
7 (26.9) |
Median day of illness on admission (IQR) |
4 (2–8) |
7 (4–9) |
8 (5–10) |
8 (5–10) |
8 (6–9) |
Median length of admission (IQR) - days |
2 (1–5) |
2 (2–3) |
4 (4–5) |
7 (6–8) |
10 (9–13) |
Number of comorbidities (%) |
0 |
22 (30.6) |
15 (37.5) |
11 (42.3) |
8 (25.0) |
7 (26.9) |
1 |
19 (26.4) |
8 (20.0) |
7 (26.9) |
11 (34.4) |
11 (42.3) |
>2 |
31 (43.1) |
17 (42.5) |
8 (30.8) |
13 (40.6) |
8 (30.8) |
Number with infiltrates of Chest X-ray (%) |
34 (47.2) |
34 (85.0) |
23 (88.5) |
31 (96.9) |
26 (100.0) |
Number of asymptomatic COVID (%) |
18 (25.0) |
0 (0.0) |
0 (0.0) |
1 (3.1) |
0 (0.0) |
Median admission sats (IQR) -% |
97 (95–98) |
93 (91–97) |
92 (90–95) |
92 (88–95) |
92 (88–94) |
Median CRP on admission (IQR) – mg/L |
24.0 (8.0–63.4) |
41.2 (24.8–77.5) |
68.0 (51.8–102.8) |
102.1 (59.8–168.9) |
98 (73–164) |
Median Urea on 1st admission (IQR) – mmol/L |
4.5 (3.6–6.9) |
4.2 (3.5–5.9) |
4.5 (3.5–5.6) |
4.4 (3.3–6.3) |
6.0 (4.8–7.3) |
Median lymphocytes on 1st admission (IQR) – x109/L |
1.01 (0.80–1.47) |
1.06 (0.79–1.32) |
0.87 (0.63–1.23) |
0.87 (0.69–1.31) |
1.00 (0.73–1.10) |
Median peak oxygen requirement (IQR) -% |
21 (21–21) |
28 (24–33) |
32 (32–36) |
40 (35–53) |
60 (40–64) |
Number of patients by peak respiratory support (%) |
Hospitalised, no oxygen |
61 (84.7) |
8 (20.0) |
1 (3.8) |
1 (3.1) |
0 (0.0) |
Oxygen by mask or nasal prongs |
10 (13.9) |
31 (77.5) |
24 (92.3) |
20 (62.5) |
9 (34.6) |
NIV or high-flow oxygen |
1 (1.4) |
0 (0.0) |
1 (3.8) |
11 (34.4) |
16 (61.5) |
Intubation and Mechanical Ventilation |
0 (0.0) |
1 (2.5) |
0 (0.0) |
0 (0.0) |
1 (3.8) |
Ventilation and additional organ support (Pressors, RRT, ECMO) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Number receiving remdesivir (%) |
0 (0.0) |
6 (15.0) |
11 (42.3) |
11 (34.4) |
13 (50.0) |
Median CRP on discharge from 1st admission (IQR) – mg/L |
22.5 (4.6–53.9) |
28.0 (16.3–62.2) |
19.9 (13.2–41.4) |
16.8 (10.2–31.1) |
12 (5.3–40.6) |
% Sats drop on exercise at discharge from 1st admission (%) |
0–1 |
21 (29.2) |
14 (35.0) |
10 (38.5) |
10 (31.3) |
6 (23.1) |
2–3 |
2 (2.8) |
8 (20.0) |
5 (19.2) |
5 (15.6) |
3 (11.5) |
≥4 |
5 (6.9) |
3 (7.5) |
7 (26.9) |
4 (12.5) |
11 (42.3) |
Unknown |
44 (61.1) |
15 (37.5) |
4 (15.4) |
13 (40.6) |
6 (23.1) |
Number discharged with steroids on 1st admission (%) |
2 (2.8) |
6 (15.0) |
1 (3.8) |
0 (0.0) |
1 (3.8) |
Number discharged with thromboprophylaxis on 1st admission (%) |
6 (8.3) |
3 (7.5) |
3 (11.5) |
7 (21.9) |
7 (26.9) |
Number discharged with saturations probe on 1st admission (%) |
8 (11.1) |
10 (25.0) |
6 (23.1) |
3 (9.4) |
6 (23.1) |
Median ISARIC 4C mortality% (IQR) |
11.7 (4.8–19.2) |
7.8 (2.3–19.2) |
11.7 (4.8–19.2) |
19.2 (11.7–26.9) |
14.4 (7.8–26.9) |
Median ISARIC 4C deterioration%(IQR) |
18.4 (12.3–24.4) |
29.4 (20.1–44.9) |
46.7 (26.6–59.7) |
56.4 (35.9–65.7) |
57.4 (40.3–65.4) |
Number receiving telephone clinic follow up on 1st admission (%) |
19 (26.4) |
16 (40.0) |
12 (46.2) |
3 (9.4) |
3 (11.5) |